Summary
The effects of 5-hydroxytryptamine (5-HT) receptor agonists on histamine turnover in mouse and rat brains were examined. The histamine turnover rate was estimated from the accumulation of tele-methylhistamine 90 min after i.p. injection of pargyline (65 mg/kg). In whole mouse brains, the histamine turnover was significantly inhibited by the 5-HT1A agonists, 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT) (> 0.5 mg/kg) and buspirone (> 2 mg/kg) injected s. c. 10 min before pargyline treatment. 5-hydroxytryptophan (20 mg/kg) also significantly inhibited histamine turnover. Injections of the 5-HT1B agonist m-trifluoromethylphenylpiperazine (10 and 20 mg/kg) or the 5-HT2 agonist (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (1, 2 and 5 mg/kg)), however, did not affect histamine turnover. The inhibitory effect of 8-OH-DPAT (1 mg/kg) on histamine turnover was significantly antagonized (by 40%) by pindolol (20 mg/kg) and slightly antagonized (by 29%) by spiperone (10 mg/kg), while methysergide (20 mg/kg) and ketanserin (10 mg/kg) demonstrated no antagonistic effects. 8-OH-DPAT (0.3 and 1 mg/kg) also showed an inhibiting effect on histamine turnover in various regions of rat brains. Although the extent of inhibition was slightly larger in the striatum and cerebral cortex, there was no marked regional difference. These results suggest that histaminergic activity in the brain is regulated by 5-HT1A receptors.
Similar content being viewed by others
References
Alexander BS, Wood MD (1988) [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum. J Pharm Pharmacol 40:888–891
Andrade R, Nicoll RA (1987) Novel anxiolytic discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 336:5–10
Baba M, Nishibori M, Oishi R, Saeki K, Kosaka F (1987) Effects of halothane, enflurane and pentobarbital on brain histamine dynamics in mice. Naunyn-Schmiedeberg's Arch Pharmacol 335:686–691
Bockaert J, Dumuis A, Bouhelal R, Sebben M, Cory RN (1987) Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons. Naunyn-Schmiedeberg's Arch Pharmacol 335:588–592
DeVivo M, Maayani S (1986) Characterization of the 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J Pharmacol Exp Ther 238:248–253
Eison AS, Eison MS, Stanley M, Riblet LA (1986) Serotonergic mechanisms in the behavioral effects of buspirone and gepirone. Pharmacol Biochem Behav 24:701–707
Engel JA, Hjorth S, Svensson K, Carlsson A, Lindequist S (1984) Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur J Pharmacol 105:365–368
Faingold CL (1978) Antihistaminics as central nervous system depressants. In: Rocha e Silva M (ed) Handbook of experimental pharmacology, vol 18, part 2. Histamine and anti-histaminics. Springer, Berlin Heidelberg New York, pp 561–571
Gozlan H, ElMestikawy S, Pichat L, Glowinski J, Hamon M (1983) Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 305:140–142
Gundelsky GA, Koenig JI, Meltzer HY (1986) Thermoregulator responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Neuropharmacology 25:1307–1313
Gulat-Marnay C, Lafitte A, Arrang JM, Schwartz JC (1989) Regulation of histamine release and synthesis in the brain by muscarinic receptors. J Neurochem 52:248–254
Gulat-Marnay C, Lafitte A, Arrang JM, Schwartz JC (1990) Modulation of histamine release in the rat brain by kappa-opioid receptors. J Neurochem 55:47–53
Hamon M, Fattaccini CM, Adrien J, Gallissot MC, Martin P, Gozlan H (1988) Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potent anxiolytic properties. J Pharmacol Exp Ther 246:745–752
Hill SJ, Straw RM (1988) α2-Adrenoceptor-mediated inhibition of histamine release from rat cerebral cortical slices. Br J Pharmacol 95:1213–1219
Hjorth S, Magnusson T (1988) The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 338:463–471
Hjorth S, Sharp T (1991) Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci 48:1779–1786
Hough LB, Khandelwal JK, Green JP (1982) Effects of pargyline on tele-methylhistamine and histamine in rat brain. Biochem Pharmacol 31:4074–4076
Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]-iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118:13–23
Huston PH, Dourish CT, Curzon G (1988) Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors. Eur J Pharmacol 150:361–366
Itoh Y, Nishibori M, Oishi R, Saeki K (1985) Changes in histamine metabolism in the mouse hypothalamus induced by acute administration of ethanol. J Neurochem 45:1880–1885
Itoh Y, Oishi R, Nishibori M, Saeki K (1987) Involvement of opioid receptors in phencyclidine-induced enhancement of brain histamine turnover in mice. Naunyn-Schmiedeberg's Arch Pharmacol 335:285–289
Itoh Y, Oishi R, Nishibori M, Saeki K (1988) Involvement of mu receptors in the opioid-induced increase in the turnover of mouse brain histamine. J Pharmacol Exp Ther 244:1021–1026
Itzhak Y, Ruhland M, Krähling H (1990) Binding of umespirone to the σ receptor: Evidence for multiple affinity states. Neuropharmacology 29:181–184
Lin JS, Sakai K, Jouvet M (1988) Evidence for histaminergic arousal mechanisms in the hypothalamus of cat. Neuropharmacology 27:111–122
Meller E, Goldstein M, Bohmaker K (1990) Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Mol Pharmacol 37:231–237
Oishi R, Nishibori M, Saeki K (1983) Regional distribution of histamine and tele-methylhistamine in the rat, mouse and guinea-pig brain. Brain Res 280:172–175
Oishi R, Nishibori M, Saeki K (1984) Regional differences in the turnover of neuronal histamine in the rat brain. Life Sci 34:691–699
Oishi R, Itoh Y, Nishibori M, Saeki K (1985) Δ9-Tetrahydrocannabinol decreases turnover of brain histamine. J Pharmacol Exp Ther 232:513–518
Oishi R, Nishibori M, Itoh Y, Saeki K (1986) Diazepam-induced decrease in histamine turnover in mouse brain. Eur J Pharmacol 124:337–342
Oishi R, Itoh Y, Nishibori M, Saeki K (1987) Feeding-related circadian variation in tele-methylhistamine levels of mouse and rat brains. J Neurochem 49:541–547
Oishi R, Adachi N, Okada K, Muroi N, Saeki K (1990) Regulation of histamine turnover via muscarinic and nicotinic receptors in the brain. J Neurochem 55:1899–1904
Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain I. Serotonin-1 receptors. Brain Res 346:205–230
Peroutka SJ (1986) Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C, binding sites in rat frontal cortex. J Neurochem 47:529–540
Peroutka SJ (1987) Serotonin receptors. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 303–311
Pollard H, Bischoff S, Schwartz JC (1973) Decreased histamine synthesis in the rat brain by hypnotics and anaesthetics. J Pharm Pharmacol 25:920–922
Saeki K, Oishi R, Nishibori M, Itoh Y (1989) Effects of isofloxythepin on central and peripheral histamine systems. Jpn J Pharmacol 50:55–62
Saeki K, Oishi R (1991) Turnover of neuronal histamine in the mammalian brain and its changes induced by drugs and observed in disease models. In: Watanabe T, Wada H (eds) Histaminergic neurons: morphology and function. CRC Press, Boca Raton, pp 345–363
Schwartz JC, Garbarg M, Pollard H (1986) Histaminergic transmission in the brain. In: Bloom FE, Mountcastle VB, Geiger SR (eds) Handbook of physiology, Sect 1, vol 4. Intrinsic regulatory systems of the brain. American Physiological Society, Bethesda, pp 257–316
Sharp T, Bramwell SR, Hijorth S, Grahame-Smith DG (1989) Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br J Pharmacol 98:989–997
Shannon M, Battaglia G, Glennon RA, Titeler M (1984) 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2.5-dimenthoxyphenyl)2-aminopropane (2,5 DMA). Eur J Pharmacol 102:23–29
Sprouse JS, Aghajanian GK (1986) (−)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur J Pharmacol 128:295–298
Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotonergic dorsal raphé neurons to 5-HT1A and 5-HT1B agonists. Synapse 1:3–9
Tricklebank MD, Forler C, Fozard JR (1985) The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol 106:271–282
Tsuruta Y, Kohashi K, Ohkura Y (1981) Simultaneous determination of histamine and Nτ-methylhistamine in human urine and rat brain by high-performance liquid chromatography with fluorescence detection. J Chromatogr 224:105–110
VandelMaelen CP, Matheson GK, Wilderman RC, Patterson LA (1986) Inhibition of serotonergic dorsal raphé neurons by systemic and iontophoretic administration of buspirone, a nonbenzodiazepine anxiolytic drug. Eur J Pharmacol 129:123–130
Watanabe T, Taguchi Y, Shiosaka S, Tanaka J, Kubota H, Terano Y, Tohyama M, Wada H (1984) Distribution of the histaminergic neuron system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 295:13–25
Author information
Authors and Affiliations
Additional information
Send offprint requests to R. Oishi at the above address
Rights and permissions
About this article
Cite this article
Oishi, R., Roh, Y. & Saeki, K. Inhibition of histamine turnover by 8-OH-DPAT, buspirone and 5-hydroxytryptophan in the mouse and rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 345, 495–499 (1992). https://doi.org/10.1007/BF00168939
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168939